Fundz

Poly Pid Ltd reported raising $35 Million in an initial SEC Form D filing, from an offering of $35 Million

PUBLIC · PYPDJan 22, 2024

Amount Raised

$35 Million

$35 Million sold, per SEC Form D (first sale Jan 9, 2024)

Round Type

Venture

IsraelManufacturingBiotechnologyTherapeuticsBiopharma

Quick answer

PolyPid raised $35 Million in a funding round, dated January 9, 2024. PolyPid is based in Israel.

How much did PolyPid raise?
PolyPid raised $35 Million in a funding round on January 9, 2024.
What does PolyPid do?
PolyPid is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes.
Where is PolyPid based and how big is it?
PolyPid is based in Israel. Fundz records about 57 employees.
Who are the decision-makers at PolyPid?
Fundz holds 2 contacts at PolyPid, including the Chief Medical Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as PolyPid that raised within 45 days of this round, from Fundz verified event records.

  • IsomAb raised $7.5M (Funding Round) on February 20, 2024.
  • IsomAb raised $7.5M (Seed) on February 20, 2024.
  • HCW Biologics raised $2.5M (Seed) on February 20, 2024.
  • Sudo Biosciences raised $147M (Series B) on February 13, 2024.
  • Adipo Therapeutics raised $1.9M (Seed) on January 31, 2024.
  • Enterprise Therapeutics Ltd raised $33M (Series B) on January 30, 2024.

Who to call at PolyPid, and when

A new round usually means PolyPid is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PolyPid raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PolyPid, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PolyPid. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PolyPid

Location

18 Hasivim Street

Israel

About

PolyPid is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the body over days to several months in a controlled manner. This allows surgeons to deliver medication right to the surgical site to improve patient outcomes in localized medical conditions such as; infection, pain, inflammation and cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PolyPid raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsNurit, Chief Medical Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PolyPid's next move

See what Strategic adds

PolyPid raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.